ArticleGeneral and comparative endocrinology2013
Acute downregulation of Type II and Type III iodothyronine deiodinases by photoperiod in peripubertal male and female Siberian hamsters.
Article in General and comparative endocrinology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 14 citations in OpenAlex.
- Divergent Photoperiodic Responses in HypothalamicAnimals : an open access journal from MDPI · 2025Article
- Article
- Effects of Environmental Endocrine-Disrupting Chemicals on Female Reproductive Health.Advances in experimental medicine and biology · 2021Article
- The Influence of Persistent Organic Pollutants on Thyroidal, Reproductive and Adrenal Hormones After Bariatric Surgery.Obesity surgery · 2020Article
- Reduced adiposity attenuates FGF21 mediated metabolic improvements in the Siberian hamster.Scientific reports · 2017Article
- EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.Endocrine reviews · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Availability of the thyroid hormone triiodothyronine (T3) in the mediobasal hypothalamus plays a central role in seasonal reproductive responses to photoperiod. Across many vertebrates, Type 2 iodothyronine deiodinase (DIO2) is elevated under reproductively stimulatory long days (LD) and synthesizes the conversion of thyroxine to T3; Type 3 iodothyronine deiodinase (DIO3) reduces T3 production and signaling, and is upregulated under reproductively-inhibitory short days (SD). In Siberian hamsters, regulation of hypothalamic T3 is dominated by dio3 expression, whereas dio2 expression is less-consistently affected by photoperiod. In adult hamsters, changes in deiodinase mRNA expression typically require several weeks to manifest, but it is not known whether or how quickly these mechanisms are engaged during the rapid responses to photoperiod observed in young, peri-pubertal hamsters. This experiment tested the hypotheses that (1) deiodinase responses to photoperiod are accelerated in juvenile hamsters and (2) photoperiodic downregulation of deiodinase expression occurs more rapidly than upregulation. Hypothalamic dio2 and dio3 mRNA expression was quantified in male and female Siberian hamsters that were weaned on postnatal day 18 (PND 18) into SD or remained in their natal LD, and on PND 31 were exposed to a single long or short day. In SD males and females, a single long day inhibited dio3 mRNA expression, but did not increase dio2 mRNA. In LD males, a single short day rapidly inhibited dio2 mRNA expression, but did not stimulate expression of dio3 mRNA. Downregulation of dio2 and dio3 mRNAs precedes gonadotrophin responses to day length. Rapid photoperiodic inhibition of deiodinase mRNAs may initiate changes in thyroid hormone signaling in advance of longer-term, melatonin-dependent, responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.